蛋白质组特征改善了对常见和罕见疾病的风险预测
Julia Carrasco-Zanini1,2,3,4, Maik Pietzner5,6,7, Jonathan Davitte8
1Human Genetics and Genomics, GSK Research and Development, Stevenage, UK. j.carrasco-zanini-sanchez@qmul.ac.uk.
Nature medicine
|July 22, 2024
概括
使用稀疏的血蛋白签名可以改善早期疾病检测. 这些新型生物标志物比传统的临床数据更准确地预测常见和罕见疾病,有助于及时诊断.
科学领域:
- 发现生物标志物的发现.
- 蛋白质组学是指蛋白质组学.
- 疾病预测 疾病预测
背景情况:
- 许多疾病的延迟诊断源于缺乏客观的早期生物标志物.
- 客观生物标志物对于改善疾病发病检测和患者治疗结果至关重要.
研究的目的:
- 使用血蛋白数据开发和验证10年疾病发病率的稀疏预测模型.
- 将蛋白质组模型的预测性能与传统的临床信息和临床试验数据进行比较.
主要方法:
- 整合了约3000个血蛋白与来自41,931名英国生物库参与者的临床数据.
- 开发了218种常见和罕见疾病的稀疏预测模型.
- 蛋白质组模型与仅临床信息和临床信息加37个测试数据模型进行了比较.
主要成果:
- 稀少蛋白质模型 (5-20 种蛋白质) 的表现优于67 种疾病的基本临床信息 (中位数delta C-index=0.07).
- 蛋白质组模型超过了52种疾病的临床测试数据模型,包括多发性骨髓瘤和运动神经元疾病.
- 在EPIC-诺福克研究中的外部验证表明了良好的概括性.
结论:
- 稀少的血蛋白签名为广泛的疾病提供了临床上有用的预测.
- 与传统的临床数据相比,蛋白质组生物标志物提供了优越的预测性能.
- 这些发现为更早,更准确的疾病诊断铺平了道路.
相关概念视频
Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K
Proteomics
7.3K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.3K


